Investigation of generic ‘cartel’ expands to 300 drugs

Source: Christopher Rowland, Washington Post (Paid Registration)

What started as an antitrust lawsuit brought by states over just two generic prescription drugs in 2016 has exploded into an investigation of alleged price-fixing involving at least 16 companies and 300 drugs. The unfolding case is rattling an industry that is portrayed in Washington as the white knight of American health care.

The alleged victims were American health-care consumers and taxpayers, who foot the bills for overcharges on common antibiotics, blood-pressure medications, arthritis treatments, anxiety pills and more, authorities say. The costs flowed throughout the system, hitting hospitals, pharmacists and health insurance companies. They hit consumers who lack prescription drug coverage and even those with insurance, because many plans have high deductibles and gaps on prescription drug benefits.

Read Full Article: Investigation of generic ‘cartel’ expands to 300 drugs

 

Tags/Keywords


 

Quick Menu

Support Consumer Action

Support Consumer

Join Our Email List

Optional Member Code
Facebook FTwitter T

Insurance Menu

Help Desk

Advocacy